Table 3.
Summary of in vitro angiogenic biomaterials
| Macroscale Platforms | ||||
|---|---|---|---|---|
| Material | Cell Types | Media | Vessel Network Quantification |
Reference |
| Collagen/fibrin | 5:1 – 1:5 HUVEC:MSC 6 × 105 cells/mL |
-- | Total length: 0.75 – 7.5 mm/mm2 Branches: 30 – 240/mm2 | [100] |
| GelMA | 1:1 ECFC:MSC 2 × 106 cells/mL |
EGM2 | Total length: 0.5 – 4 mm/mm2 Branches: 10 – 30/mm2 | [187] |
| Collagen | 1:5:1 RBE4:AC:PC 5 × 105 RBE4s/mL |
Alpha MEM/ Ham’s F10 + 20% rat serum | Average branch length: 0.15 – 0.25 mm Branches: 100 – 400/construct | [182] |
| Fibrin | 5:1 HUVEC:NHLF 0.1 × 105 – 3 × 106 HUVECs/mL |
EGM2 | Total length: 4 – 12 mm/mm2 Branches: 1 – 1.5/vessel network | [188] |
| Fibrin | 5:1 – 1:2 EC:FB 1 × 106 HUVECs/mL |
EGM2 | Total length: 4 – 12 mm/mm2 Branches: 20 – 70/mm2 | [189] |
| PEGGGGPQGIWGQGK + RGD + VEGF | 4:1 HUVEC:10T1/2 30 × 106 cells/mL |
EGM2 | Total length: 0.8 mm | [191] |
| GelMA | 1:2 HUVEC:NHLF 1.5 × 106 – 6 × 106 cells/mL |
EGM2 | Total length: 25–50 mm/mm3 Branches: 500 – 7500/mm3 | [202] |
| PEG/PLL | 10:1 EC:NPC 1 × 106 HUVECs/implant | DMEM + 10% FBS | Branches: 2/area |
[277] |
| Collagen | 5.5 × 105 – 2.2 × 106 iPSC-EP | EGM2/SMGM2 | Total length: 0.4 – 10 mm/slice Branches: 1020/slice | [181] |
| PEG Heparin + GCGGPQGIWGQGGCG + RGD + VEGF + bFGF + SDF1a |
6 × 106 HUVECs/mL MSC/HDF/SMC/10T1/2 |
ECGM | Total length: 520 mm/mm2 Branches: 0–60/mm2 | [201] |
| PEG/PPLGgPEG GPQIWQG + RGD |
12 × 106 iPS-ECs/mL | VascuLife + iCell supplement | Total length: 560 mm/image volume | [193] |
| PEGKCGGPQGIWGQGCK + RGD | 2:1 ESC-EC:PC 1.7 × 106 HUVECs/mL |
E7V | Total area: 3040 mm2/mm2 Branch points: 0.1–0.15/mm2 | [251] |
| PEGGCRDVPMSMRGGDRCG + RGD | 1:1 HUVEC:NHDF 4 × 106 cells/mL |
VascuLife | Total length: 20–50 mm/mm2 | [194] |
| Hyaluronic acid RGD | 1:1 HUVEC:HFF-1 4 × 106 cells/mL |
EGM2 | Average branch length: 0.07 – 0.30 mm | [321] |
| PCL/collagen/hyaluronic acid VEGF + PDGFBB |
1:1, 1:3, 1:5 HUVEC:FB 5 × 104 – 5 × 105 HUVECs/mL |
EBM2 | Average branch length: 0.15 mm | [210] |
| PEG/collagen | 1:1 HUVEC:NHLF | EGM2 | Total length: 15 mm/ROI | [211] |
| Microfluidic Platforms | ||||
| Fibrin | 1:2 – 2:1 HUVEC:NHLF 1 × 106 – 4 × 106 HUVECs/mL |
EGM2-MV | Average branch length: 0.05 – 0.11 mm Branches: 90–250/mm2 | [224] |
| Fibrin | 2:1 HUVEC:MSC 12 × 106 HUVECs/mL |
EGM2-MV | Total length: 813 mm/ROI Branches: 90–150/mm2 | [225] |
| Fibrin | 3:1:1 iPS-EC:PC:AC 6 × 106 HUVECs/mL |
VascuLife + iCell supplement | Average branch length: 0.15 – 0.25 mm | [226] |
| Fibrin | 2:1 iPS-EC:NHLF 1 × 107 HUVECs/mL |
EGM2 | Total length: 6 mm/ROI | [243] |
EC: endothelial cell; FB: fibroblast; HUVEC: human umbilical vein endothelial cell; MSC: mesenchymal stem cell; ECFC: endothelial colony-forming cell; RBE: rat brain endothelial; AC: astrocyte; PC: pericyte; NHLF: normal human lung fibroblast; HFF-1: human foreskin fibroblast; NPC: neural progenitor cell; iPSC-EP: induced pluripotent stem cell - endothelial progenitor; HDF: human dermal fibroblast; SMC: smooth muscle cell; iPS-EC: induced pluripotent stem - endothelial cell; ESC-EC: embryonic stem cell - endothelial cell; NHDF: normal human dermal fibroblast; ROI: region of interest; GelMA: methacrylamide-functionalized gelatin; PEG: polyethylene glycol; PLL: poly-L-lysine; PPLG: poly (propargyl-L-glutamate); PCL: polycaprolactone